| 000 | 01204 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513002315.0 | ||
| 264 | 0 | _c19800928 | |
| 008 | 198009s 0 0 eng d | ||
| 022 | _a0021-9258 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMagun, B E | |
| 245 | 0 | 0 |
_aEpidermal growth factor. Ability of tumor promoter to alter its degradation, receptor affinity and receptor number. _h[electronic resource] |
| 260 |
_bThe Journal of biological chemistry _cJul 1980 |
||
| 300 |
_a6373-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEpidermal Growth Factor _xmetabolism |
| 650 | 0 | 4 |
_aFibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aMonoiodotyrosine _xbiosynthesis |
| 650 | 0 | 4 |
_aPeptides _xmetabolism |
| 650 | 0 | 4 |
_aPhorbols _xpharmacology |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, Drug _xdrug effects |
| 650 | 0 | 4 | _aTemperature |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xpharmacology |
| 700 | 1 | _aMatrisian, L M | |
| 700 | 1 | _aBowden, G T | |
| 773 | 0 |
_tThe Journal of biological chemistry _gvol. 255 _gno. 13 _gp. 6373-81 |
|
| 999 |
_c6966744 _d6966744 |
||